Nuclear Regulatory Commission July 28, 2020 – Federal Register Recent Federal Regulation Documents
Results 1 - 3 of 3
Advisory Committee on the Medical Uses of Isotopes: Meeting Notice
The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on September 21-22, 2020. A sample of agenda items to be discussed during the public session includes: A discussion of the ACMUI's review and analysis of medical events from fiscal year 2019; a discussion of the ACMUI's review and analysis of non-medical events from fiscal year 2019; a discussion on the U.S. Food and Drug Administration's regulatory process for the development of drugs and devices; an update on the NRC's Phase 2 revision of Regulatory Guide 8.39, ``Release of Patients Administered Radioactive Material''; and an update on the activities of the NRC's Medical Radiation Safety Team. The agenda is subject to change. The current agenda and any updates will be available on the ACMUI's Meetings and Related Documents web page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings / 2020.html or by emailing Ms. Kellee Jamerson at the contact information below. Purpose: Discuss issues related to 10 CFR part 35 Medical Use of Byproduct Material. Date and Time for Open Sessions: September 21, 2020, from 10 a.m. to 2 p.m. and September 22, 2020, from 12:15 p.m. to 1:45 p.m. Eastern Standard Time (EST).
Information Collection: NRC Form 4, Cumulative Occupational Exposure History
The U.S. Nuclear Regulatory Commission (NRC) has recently submitted a request for renewal of an existing collection of information to the Office of Management and Budget (OMB) for review. The information collection is entitled, ``NRC Form 4, Cumulative Occupational Exposure History.''
Biweekly Notice; Applications and Amendments to Facility Operating Licenses and Combined Licenses Involving No Significant Hazards Considerations
Pursuant to section 189.a.(2) of the Atomic Energy Act of 1954, as amended (the Act), the U.S. Nuclear Regulatory Commission (NRC) is publishing this regular biweekly notice. The Act requires the Commission to publish notice of any amendments issued, or proposed to be issued, and grants the Commission the authority to issue and make immediately effective any amendment to an operating license or combined license, as applicable, upon a determination by the Commission that such amendment involves no significant hazards consideration (NSHC), notwithstanding the pendency before the Commission of a request for a hearing from any person. This biweekly notice includes all amendments issued, or proposed to be issued, from June 29, 2020, to July 13, 2020. The last biweekly notice was published on July 14, 2020.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
